摘要
1997年日本首次报道检出异质性万古霉素中介金黄色葡萄球菌(heterogeneous vancomycin-intermediate Staphylococcus aureus,hVISA),并引起万古霉素治疗失败。如今世界各地均有报道,且检出率逐年升高,已引起临床及实验室的高度关注。本文对hVISA的流行性、实验室检测及临床意义等方面综述如下。
Heterogeneous vancomycin-intermediate Staphylococcus aureus （hVISA） was first identified and reported to cause vancomycin treatment failure in Japan in 1997. Now, hVISA isolations have been reported worldwide. Moreover, the prevalence of hVISA increased year by year, which has drawn great attention from both the clinical and laboratory. This article gives a summary on the epidemiological analysis, detection and the clinical significance of the hVISA.
出处
《中华临床实验室管理电子杂志》
2013年第1期24-29,共6页
Chinese Journal of Clinical Laboratory Management(Electronic Edition）
基金
国家"十二.五"科技重大专项子课题资助项目(2012ZX10004207-004)
关键词
万古霉素
葡萄球菌
金黄色
抗药性
细菌
Vancomycin
Staphylococcus, aureus
Drug resistance, bacterial
